{
    "relation": [
        [
            "",
            "*",
            "(1)",
            "(2)",
            "(3)",
            "(4)",
            "(5)",
            "(6)",
            "(7)",
            "(8)",
            "(9)",
            "(10)",
            "(11)",
            "(12)",
            "(13)"
        ],
        [
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "",
            "1% or less",
            "Percentage of beneficial ownership is based on 401,205,801 shares of common stock outstanding as of September 28, 2007. Shares of common stock subject to options currently exercisable, or exercisable within 60 days of September 28, 2007, are deemed outstanding for computing the percentage of the person holding such options but are not deemed outstanding for computing the percentage for any other person.",
            "Represents shares beneficially owned by Citadel Limited Partnership, Citadel Investment Group, L.L.C., Kenneth Griffin, Citadel Equity Fund Ltd., Citadel Derivatives Group LLC, based on a Schedule 13D/A that was filed jointly by these individuals and entities with the SEC on July 2, 2007.",
            "Represents shares beneficially owned by Barclays Global Investors, NA., Barclays Global Fund Advisors, Barclays Global Investors, Ltd, Barclays Global Investors Japan Trust and Banking Company Limited, Barclays Global Investors Japan Limited, based on a Schedule 13G that was filed jointly by these entities with the SEC on January 23, 2007.",
            "Includes 708,146 shares of common stock held in the Eric and Illeana Benhamou Living Trust dated September 11, 2000, of which Mr. Benhamou is a co-trustee.",
            "Includes 333,333 unvested shares of restricted stock issued to Mr. Masri.",
            "Consists of 300,000 unvested shares of restricted stock issued to Mr. Zager.",
            "Includes 438,333 unvested shares of restricted stock issued to Mr. Goldman.",
            "Includes 250,000 unvested shares of restricted stock issued to Mr. Hamilton.",
            "Consists of 200,000 unvested restricted stock units issued to Dr. Zheng.",
            "Includes 330,000 unvested shares of restricted stock issued to Dr. Willebeek-LeMair. Dr. Willebeek-LeMair (while still currently a 3Com officer) ceased to be an executive officer on March 28, 2007.",
            "Mr. Halsted is the Company\u0092s former Executive Vice President and Chief Financial Officer. He resigned from those positions as of June 22, 2007, and his employment with the Company terminated July 27, 2007.",
            "Mr. Murray is the Company\u0092s former President and Chief Executive Officer. He resigned from those positions as of the close of business on August 17, 2006.",
            "Includes 1,801,666 unvested shares of restricted stock issued to current executive officers (including 280,000 shares held by Robert Dechant, our Senior Vice President and General Manager, Data and Voice Business Unit)."
        ]
    ],
    "pageTitle": "prem14a",
    "title": "",
    "url": "http://www.sec.gov/Archives/edgar/data/738076/000095013507006319/b67013prprem14a.htm",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 111,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042989042.37/warc/CC-MAIN-20150728002309-00287-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 702892855,
    "recordOffset": 702727506,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Mon, 24 Mar 2008 13:25:04 GMT",
    "textBeforeTable": "\u00a0 The following questions and answers are intended to address briefly some commonly asked questions regarding the Merger, the Merger Agreement and the special meeting. These questions and answers may not address all questions that may be important to you as a 3Com stockholder. Please refer to the \u0093Summary\u0094 and the more detailed information contained elsewhere in this proxy statement, the annexes to this proxy statement and the documents referred to or incorporated by reference in this proxy statement, which you should read carefully. See \u0093Where You Can Find More Information\u0094 beginning on page\u00a072. \u00a0 QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER \u00a0 Table of Contents 8 Our Common Stock is listed on the Nasdaq Global Select Market (\u0093Nasdaq\u0094) under the trading symbol \u0093COMS.\u0094 The closing",
    "textAfterTable": "A. Approval of the proposal to adjourn or postpone the special meeting, if necessary or appropriate, for the purpose of soliciting additional proxies requires the affirmative vote of a majority of the votes cast by the holders of all Common Stock present in person or represented by proxy at the special meeting and entitled to vote on the matter. \u00a0 Q. How does 3Com\u0092s board of directors recommend that I vote? \u00a0 A. The board of directors unanimously recommends that you vote \u0093FOR\u0094 the proposal to adopt the Merger Agreement and \u0093FOR\u0094 the proposal to adjourn or postpone the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to adopt the Merger Agreement. You should read \u0093The Merger\u00a0\u0097 Reasons for the Merger; Recommendation of our Board of Directors\u0094 beginning on page 25 for a discussion of the factors that the board of directors considered in deciding to recommend the adoption of the Merger Agreement. 9 Table of Contents",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}